3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Prostatic Neoplasms
56
Lung Neoplasms
48
Leukemia, Myeloid, Acute
44
Breast Neoplasms
37
Carcinoma, Non-Small-Cell Lung
36
Myelodysplastic Syndromes
27
Pancreatic Neoplasms
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Multiple Myeloma
23
Colorectal Neoplasms
23
Carcinoma, Renal Cell
22
Neoplasm Metastasis
20
Melanoma
20
Glioblastoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Ovarian Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
17
Brain Neoplasms
16
Triple Negative Breast Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
12
Carcinoma, Hepatocellular
12
Lymphoma, Mantle-Cell
11
Lymphoma, B-Cell
11
Leukemia, Myelomonocytic, Chronic
11
Fallopian Tube Neoplasms
11
Rectal Neoplasms
10
Myeloproliferative Disorders
10
Lymphoma, Follicular
10
Colonic Neoplasms
10
Hematopoietic and Lymphatic System Neoplasm
9
Interventions
Exercise
5
Vitamin D
3
Resistance Training
3
Ascorbic Acid
3
salicylsalicylic acid
2
palbociclib
2
epigallocatechin gallate
2
Tea
2
Tablets
2
Surgical Procedures, Operative
2
Sufentanil
2
Spironolactone
2
Oxycodone
2
Omeprazole
2
Nutrition Assessment
2
Morphine
2
Metformin
2
Ketorolac
2
Infliximab
2
Ibuprofen
2
Fish Oils
2
Endurance Training
2
Dexmedetomidine
2
Blood Specimen Collection
2
Aspirin
2
ziprasidone
1
soybean oil, phospholipid emulsion
1
semaglutide
1
montelukast
1
microcrystalline cellulose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Inflammation
×
Specimen Handling
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled